Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

36.04
Delayed Data
As of Sep 04
 +0.63 / +1.78%
Today’s Change
31.36
Today|||52-Week Range
45.35
-11.54%
Year-to-Date

Today’s Trading

Previous close35.41
Today’s open34.99
Day’s range34.55 - 36.24
Volume158,117
Average volume (3 months)140,539
Market cap$518.1M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+80.58%
Earnings growth (this year)-43.33%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+40.64%
P/E ratio21.6
Price/Sales5.89
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
INOInovio Pharmaceutica...+0.02+0.28%
ANGOAngioDynamics Inc-0.06-0.41%
CERSCerus Corp+0.31+6.29%
RMTIRockwell Medical Inc+0.58+5.01%
Data as of 4:14pm ET, 09/04/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)$0.34
Annual revenue (last year)$105.6M
Annual profit (last year)$38.3M
Net profit margin36.29%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Francesco J. Luppino
Corporate headquarters
Bedford, Massachusetts

Forecasts

Partner Offers